ESC 365 - LDL cholesterol after acute coronary syndrome: is lower better?

ACVC Premium Access

LDL cholesterol after acute coronary syndrome: is lower better?

Session: Poster Session 3 - Clinical pharmacology and pharmacotherapy

Topic: Clinical Pharmacology and pharmacotherapy

Speaker: Mr A. chacon pinero (Badajoz, ES)

Event: Acute Cardiovascular Care 2016

Congress Presentation

Add to my library

About the speaker

Mr Antonio chacon pinero

Hospital Universitario Infanta Cristina, Badajoz (Spain)

1 presentation

0 follower

4 more presentations in this session

Evaluation of the clinical significance of antibiotics for fever after acute myocardial infarction

Speaker: Doctor Y. Mizuguchi (Kobe, JP)

Ticagrelor in ST elevation myocardial infarction: the impact in a real world population

Speaker: Doctor B. Brochado (Porto, PT)

Real-life experience and safety evaluation test with levosimendan in cardiogenic shock due to acute coronary syndrome.

Speaker: Mr A. Roldan (Madrid, ES)

Real-world comparision of evidence-based cardiovascular drugs in patients with history of ischemic heart disease and hypertension before the onset of acute coronary syndrome

Speaker: Doctor C. Matei (Baia Mare, RO)

Access the full session

Poster Session 3 - Clinical pharmacology and pharmacotherapy

Speakers: Mr A. chacon pinero, Doctor Y. Mizuguchi, Doctor B. Brochado, Mr A. Roldan, Doctor C. Matei

About the event

Acute Cardiovascular Care 2016

15 October - 17 October 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources